IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2020

Incisional Hernias Post Liver Transplantation: Current Evidence of Epidemiology, Risk Factors and Laparoscopic Versus Open Repair. A Review of the Literature. N. GARMPIS, E. SPARTALIS, D. SCHIZAS, D. PATSOURAS, C. DAMASKOS, M. SPARTALIS, A. GARMPI, N.I. NIKITEAS, D. DIMITROULIS (Athens, Greece). In Vivo 33: 1059-1066, 2019.
Pharmacogenetic Implications of eNOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy. A. COZMA, A. FODOR, O.H. ORASAN, R. VULTURAR, D. SAMPLELEAN, V. NEGREAN, C. MURESAN, R. SUHAROSCHI, A. SITAR-TAUT (Cluj-Napoca, Romania). In Vivo 33: 1051-1058, 2019.
Screening and Risk Assessment of Coronary Artery Disease in Patients With Type 2 Diabetes: An Updated Review. A. PATSOURAS, P. FARMAKI, A. GARMPI, C. DAMASKOS, N. GARMPIS, D. MANTAS, E. DIAMANTIS (Athens, Greece). In Vivo 33: 1039-1050, 2019.
Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer. V. MALY, O. MALY, K. KOLOSTOVA, V. BOBEK (Prague; Usti nad Labem; Wroclaw, Poland). In Vivo 33: 1027-1038, 2019
Plasma Medicine: A Field of Applied Redox Biology. T. VON WOEDTKE, A. SCHMIDT, S. BEKESCHUS, K. WENDE, K.-D. WELTMANN (Greifswald, Germany). In Vivo 33: 1011-1026, 2019.
Potential Applications of Non-thermal Plasma in Animal Husbandry to Improve Infrastructure. T. KWON, N. CHANDIMALI, D.-H. LEE, Y. SON, S.-B. YOON, J. LEE, S. LEE, K.J. KIM, S.-Y. LEE, S.-Y. KIM, Y.-J. JO, M. KIM, B.-J. PARK, J.-K. LEE, D.K. JEONG, J.-S. KIM (Jeonbuk; Daejeon; Jeju, Republic of Korea). In Vivo 33:999-1010, 2019
Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review. K. MOKBEL, K. MOKBEL (London, UK). In Vivo 33: 983-998, 2019.
Enhanced Recovery After Surgery: Is It Time to Change Our Strategy Regarding Laparoscopic Colectomy? N. GARMPIS, D. DIMITROULIS, A. GARMPI, E. DIAMANTIS, E. SPARTALIS, D. SCHIZAS, A. ANGELOU, G.-A. MARGONIS, P. FARMAKI, E.A. ANTONIOU, D. MANTAS, K. MARKATOS, K. KONTZOGLOU, C. DAMASKOS (Athens, Greece; Baltimore, MD, USA). In Vivo 33: 669-674, 2019.
The Role of ARID1A in Endometrial Cancer and the Molecular Pathways Associated With Pathogenesis and Cancer Progression. C. TOUMPEKI, A. LIBERIS, I. TSIRKAS, T. TSIRKA, S. KALAGASIDOU, L. INAGAMOVA, X. ANTHOULAKI, G. TSATSARIS, E.N. KONTOMANOLIS (Alexandroupolis; Thessaloniki; Ptolemaida, Greece). In Vivo 33: 659-667, 2019.
The Role of 3D Printing in Colorectal Surgery: Current Evidence and Future Perspectives. X. PAPAZARKADAS, E. SPARTALIS, D. PATSOURAS, A. IOANNIDIS, D. SCHIZAS, K. GEORGIOU, D. DIMITROULIS, N. NIKITEAS (Athens, Greece). In Vivo 33: 297-302, 2019
Oxidative Stress and Oral Mucosal Diseases: An Overview. N. SARDARO, F. DELLA VELLA, M.A. INCALZA, D. DI STASIO, A. LUCCHESE, M. CONTALDO, C. LAUDADIO, M. PETRUZZI (Bari; Naples, Italy). In Vivo 33: 289-296, 2019.
Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology. F. FITENI, A. CUENANT, M. FAVIER, C. COUSIN, N. HOUEDE (Nimes; Montpellier, France). In Vivo 33: 17-21, 2019.
Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern. M. SHIMADA, Y. SHUTTO-UCHITA, H. YAMABE (Hirosaki; Namegata, Japan). In Vivo 33: 11-16, 2019.
Reconstructive Surgery of Inguinal Defects: A Systematic Literature Review of Surgical Etiology and Reconstructive Technique. K. SÖRELIUS, L. SCHIRALDI, S. GIORDANO, C.M. ORANGES, W. RAFFOUL, P.G. DI SUMMA (Uppsala, Sweden; Lausanne; Basel, Switzerland; Turku, Finland). In Vivo 33: 1-9, 2019.
Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice. R. GERA, A. KASEM, K. MOKBEL (London, UK). In Vivo 32: 1301-1307, 2018.
Treatment of Articular Cartilage Defects: Focus on Tissue Engineering. B. ŻYLIŃSKA, P. SILMANOWICZ, A. SOBCZYŃSKA-RAK, Ł. JAROSZ, T. SZPONDER (Lublin, Poland). In Vivo 32: 1289-1300, 2018.
Cysts and Pseudocysts of the Oral Cavity: Revision of the Literature and a New Proposed Classification. D. MENDITTI, L. LAINO, M. DI DOMENICO, G. TROIANO, M. GUGLIELMOTTI, S. SAVA, A. MEZZOGIORNO, A. BALDI (Naples, Italy). In Vivo 32:999-1007, 2018.
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis. A.R. ALRAFIAH (Jeddah, Saudi Arabia). In Vivo 32:983-998, 2018.
Vitamin D in Cardiovascular Disease. A. NITSA, M. TOUTOUZA, N. MACHAIRAS, A. MARIOLIS, A. PHILIPPOU, M. KOUTSILIERIS (Athens; Areopolis, Greece). In Vivo 32:977-981, 2018.
Considerations Regarding Embryo Culture Conditions: From Media to Epigenetics. M. SIMOPOULOU, K. SFAKIANOUDIS, A. RAPANI, P. GIANNELOU, G. ANIFANDIS, S. BOLARIS, A. PANTOU, M. LAMBROPOULOU, A. PAPPAS, E. DELIGEOROGLOU, K. PANTOS, M. KOUTSILIERIS (Athens; Larissa; Alexandroupolis, Greece). In Vivo 32:451-460, 2018.
Non Lipomatous Benign Lesions Mimicking Soft-tissue Sarcomas: A Pictorial Essay. A. CORAN, G. ORSATTI, F. CRIMÌ, M. RASTRELLI, A. DI MAGGIO, A. PONZONI, S. ATTAR, R. STRAMARE (Padua, Italy). In Vivo 32:221-229, 2018.
In Vivo Analysis of Prostaglandins-induced Ocular Surface and Periocular Adnexa Modifications in Patients with Glaucoma. S. DI STASO, L. AGNIFILI, S. CECANNECCHIA, A. DI GREGORIO, M. CIANCAGLINI (L’Aquila; Chieti, Italy). In Vivo 32:211-220, 2018.
Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer. E.S. WENZEL, A.T.K. SINGH (Kenosha, WI, USA). In Vivo 32:1-5, 2018.
Tailoring the ‘Perfect Fit’ for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy. C. ARGYROU, D. MORIS, S. VERNADAKIS (Athens, Greece; Columbus, OH, USA). In Vivo 31:307-312, 2017.
The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice. L. HOLUBEC, J. POLIVKA, L. LISNEROVA, T. KUBIKOVA, M. SAFANDA (Pilsen; Prague, Czech Republic). In Vivo 31:303-306, 2017.
Laparoscopic Splenectomy for Benign Hematological Disorders in Adults: A Systematic Review. D. MORIS, N. DIMITRIOU, J. GRINIATSOS (Columbus, OH, USA; Athens, Greece). In Vivo 31:291-302, 2017.
Factors Associated with Microalbuminuria Remission in Patients with Type 2 Diabetes: Importance of Early Intervention for Microalbuminuric Patients (TSUGARU STUDY). N. NAKAMURA, I. NARITA, T. FUJITA, R. MURAKAMI, M. SHIMADA, M. NAKAMURA, H. OSAWA, H. YAMABE, K. OKUMURA (Aomori, Japan). In Vivo 31:285-290, 2017.
The Use of Proteomics in Assisted Reproduction. I. KOSTERIA, A.K. ANAGNOSTOPOULOS, C. KANAKA-GANTENBEIN, G.P. CHROUSOS, G.T. TSANGARIS (Athens, Greece).In Vivo 31: 267-283, 2017.
Clinical Factors Associated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer. L. DZIGGEL, S.E. SCHILD, T. VENINGA, A. BAJROVIC, D. RADES (Lübeck; Hamburg, Germany; Scottsdale, AZ, USA; Tilburg, the Netherlands).In Vivo 31: 35-38, 2017.
Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review. C. PERISANIDIS (Vienna, Austria).In Vivo 31: 23-34 , 2017.
Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies. A. NOGUEIRA, M.J. PIRES, P.A. OLIVEIRA (Vila Real; Bragança, Portugal). In Vivo 31: 1-22 , 2017.
The Correction of Aphakia Using Anterior Chamber Intraocular Lens. M.M. MOSCHOS, E. NITODA (Athens, Greece). In Vivo 30: 733-738, 2016.
Plasma Cell Mastitis In Men: A Single-center Experience and Review of the Literature.  A. PALMIERI, V. D’ORAZI, G. MARTINO, F. FRUSONE, D. CROCETTI, M.I. AMABILE, M. MONTI (Rome, Italy). In Vivo 30: 727-732, 2016.
Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems. E. BAGLI, A. GOUSSIA, M.M. MOSCHOS, N. AGNANTIS, G. KITSOS (Ioannina; Athens, Greece). In Vivo 30: 535-547, 2016.
Making ICSI Safer and More Effective: A Review of the Human Oocyte and ICSI Practice. M. SIMOPOULOU, P. GIANNELOU, P. BAKAS, L. GKOLES, T. KALAMPOKAS, K. PANTOS, M. KOUTSILIERIS (Athens, Greece). In Vivo 30: 387-400, 2016.
Renal Subcapsular Space of Balb/c Nude Mice as a Route for Evaluating Subpopulations of Human Bladder Carcinoma Cells. D.M. SOUZA, L.H.G. MATHEUS, C.S. SILVA, J.M. FERREIRA, H. DELLÊ (São Paulo, Brazil). In Vivo 30: 383-386, 2016.
Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.  A. JANECKA, M. KOŁODZIEJ-RZEPA, B. BIESAGA (Cracow, Poland). In Vivo 30: 375-381, 2016.
Propeller Flaps: A Literature Review. A. SISTI, C. D’ANIELLO, L. FORTEZZA, J. TASSINARI, R. CUOMO, L. GRIMALDI, G. NISI (Siena, Italy). In Vivo 30: 351-373, 2016.
A Three-phase Approach for the Early Identification of Acute Lung Injury Induced by Severe Sepsis. T. MIYASHITA, A.K. AHMED, S. NAKANUMA, K. OKAMOTO, S. SAKAI, J. KINOSHITA, I. MAKINO, K. NAKAMURA, H. HAYASHI, K. OYAMA, H. TAJIMA, H. TAKAMURA, I. NINOMIYA, S. FUSHIDA, J.W. HARMON, T. OHTA (Kanazawa, Japan; Baltimore, MD, USA). In Vivo 30: 341-349, 2016.
Prominent Anti-UV Activity and Possible Cosmetic Potential of Lignin-carbohydrate Complex. H. SAKAGAMI, H. SHENG, N. OKUDAIRA, T. YASUI, H. WAKABAYASHI, J. JIA, T. NATORI, M. SUGURO-KITAJIMA, H. OIZUMI, T. OIZUMI (Sakado; Kanagawa, Japan). In Vivo 30: 331-339, 2016.
Postsurgical Hypoparathyroidism: A Systematic Review. K. KAKAVA, S. TOURNIS, G. PAPADAKIS, I. KARELAS, P. STAMPOULOGLOU, E. KASSI, I. TRIANTAFILLOPOULOS, V. VILLIOTOU, T. KARATZAS (Piraeus; Athens, Greece). In Vivo 30: 171-179, 2016.
Comparison of International Guidelines on Mucosal Melanoma of the Head and Neck: A Comprehensive Review of the Role of Radiation Therapy. M. PITTAKA, D. KARDAMAKIS, D. SPYROPOULOU (Patras, Greece). In Vivo 30: 165-170, 2016.
The Role of Insulin-like Growth Factor-1 Signaling Pathways in Uterine Leiomyoma. E. GKIOKA, P. MSAOUEL, A. PHILIPPOU, N.I. VLACHOGIANNIS, C.T. VOGKOU, A. MARGIOLIS, M. KOUTSILIERIS (Athens; Areopolis, Greece; Bronx, NY, USA). In Vivo 29: 637-649, 2015.
The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. P.P. SORDILLO, D.C. SORDILLO, L. HELSON (Quakertown, PA, USA). In Vivo 29: 619-636, 2015.
The Spectrum of Infectious Diseases in Kidney Transplantation: A Review of the Classification, Pathogens and Clinical Manifestations. N.-A. ANASTASOPOULOS, A. DUNI, D. PESCHOS, N. AGNANTIS, E. DOUNOUSI (Ioannina, Greece). In Vivo 29: 415-422, 2015.
Vasculogenic Mimicry: Lessons from Melanocytic Tumors. K. SPILIOPOULOS, D. PESCHOS, A. BATISTATOU, I. NTOUNTAS, N. AGNANTIS, G. KITSOS (Ioannina; Athens, Greece). In Vivo 29: 309-317, 2015.
MicroRNAs in Assisted Reproduction and their Potential Role in IVF Failure. C. SIRISTATIDIS, P. VOGIATZI, N. BRACHNIS, A. LIASSIDOU, Z. ILIODROMITI, S. BETTOCCHI, C. CHRELIAS (Athens, Greece; Bari, Italy). In Vivo 29: 169-175, 2015.
Antibiotic Discovery in the Age of Structural Biology – A Comprehensive Overview with Special Reference to Development of Drugs for the Treatment of Pseudomonas aeruginosa Infection. A. KOEHNKE, R.E. FRIEDRICH (Hamburg; Kiel, Germany). In Vivo 29: 161-167, 2015.
Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with
Ebola and Other Severe Viral Infections. P.P. SORDILLO, L. HELSON (Quakertown, PA, USA). In Vivo 29: 1-4, 2015.
Cardiopulmonary Exercise Testing (CPET) as Preoperative Test Before Lung Resection. A. KALLIANOS, A. RAPTI, S. TSIMPOUKIS, A. CHARPIDOU, I. DANNOS, E. KAINIS, K. SYRIGOS (Athens, Greece). In Vivo 28: 1013-1020, 2014.
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification. M. RASTRELLI, S. TROPEA, C.R. ROSSI, M. ALAIBAC (Padova, Italy). In Vivo 28: 1005-1011, 2014.
Cell Adhesion Molecules and In Vitro Fertilization. M. SIMOPOULOU, E. NIKOLOPOULOU, A. DIMAKAKOS, K. CHARALABOPOULOS, M. KOUTSILIERIS (Athens; Alexandroupolis, Greece). In Vivo 28: 683-690, 2014.
The WT1 Gene – Its Role in Tumourigenesis and Prospects for Immunotherapeutic Advances. I. LINDSTEDT, M. A. LINDGREN, E. ANDERSSON, W. ENGSTRÖM (Uppsala, Sweden). In Vivo 28: 675-681, 2014.
Circulating miR-18a: A Sensitive Cancer Screening Biomarker in Human Cancer. S. KOMATSU, D. ICHIKAWA, H. TAKESHITA, R. MORIMURA, S. HIRAJIMA, M. TSUJIURA, T. KAWAGUCHI, M. MIYAMAE, H. NAGATA, H. KONISHI, A. SHIOZAKI, E. OTSUJI (Kyoto, Japan). In Vivo 28: 293-297, 2014.
Post-translational Histone Modifications in Circulating Nucleosomes as New Biomarkers in Colorectal Cancer. U. GEZER, S. HOLDENRIEDER (Istanbul, Turkey; Bonn, Germany). In Vivo 28: 287-292, 2014.
Melanoma m1: Diagnosis and Therapy. M. RASTRELLI, S. TROPEA, J. PIGOZZO, E. BEZZON, L.G. CAMPANA, R. STRAMARE, M. ALAIBAC, C.R. ROSSI (Padova, Italy). In Vivo 28: 273-285, 2014.
Mechanisms by which Thioridazine in Combination with Antibiotics Cures Extensively Drugresistant Infections of Pulmonary Tuberculosis. L. AMARAL, J. MOLNAR (Lisbon, Portugal; Szeged, Hungary). In Vivo 28: 267-271, 2014.
Vitamin D3 Deficiency Results in Dysfunctions of Immunity with Severe Fatigue and Depression in a Variety of Diseases. A.D. HÖCK (Cologne, Germany). In Vivo 28: 133-145, 2014.
Role of Cytokines as a Double-edged Sword in Sepsis. H. CHAUDHRY, J. ZHOU, Y. ZHONG, M.M. ALI, F. MCGUIRE, P.S. NAGARKATTI, M. NAGARKATTI (Columbia, SC, USA; Yantai, Shandong, PR China). In Vivo 27: 669-684, 2013.
Vitamin C: Electron Emission, Free Radicals and Biological Versatility. N. GETOFF (Vienna, Austria). In Vivo 27: 565-570, 2013.
Smoking Cessation Strategies in Patients with Lung Disease. G. TSIAPA, I. GKIOZOS, K. SOULIOTIS, K. SYRIGOS (Athens, Greece). In Vivo 27: 171-176, 2013.
Advances in Non-invasive Prenatal Diagnosis. A.G. VAIOPOULOS, K.C. ATHANASOULA, N. PAPANTONIOU, A. KOLIALEXI (Athens, Greece). In Vivo 27: 165-170, 2013.
Description of the Developmental Patterns of Epithelial Cells and Cancers Originating from Them Will Provide Many Sites for Therapy. K.M. ANDERSON, P. GUINAN, M. RUBENSTEIN (Chicago, IL, USA). In Vivo 27: 159-163, 2013.
Breast Cancer: Mechanisms Involved in Action of Phytoestrogens and Epigenetic Changes. A. DAGDEMIR, J. DURIF, M. NGOLLO, Y.-J. BIGNON, D. BERNARD-GALLON (Clermont-Ferrand, France). In Vivo 27: 1-9, 2013.
Impact of Mediators Present in Amniotic Fluid on Preterm Labour. N. VRACHNIS, S. KARAVOLOS, Z. ILIODROMITI, S. SIFAKIS, C. SIRISTATIDIS, G. MASTORAKOS and G. CREATSAS (Athens; Heraklion, Greece; Gateshead, United Kingdom). In Vivo 26: 799-812, 2012.
Chios Mastic Gum: A Plant-produced Resin Exhibiting Numerous Diverse Pharmaceutical and Biomedical Properties. K.S. DIMAS, P. PANTAZIS and R. RAMANUJAM (Larissa, Greece; Columbus, OH, USA). In Vivo 26: 777-785, 2012.
BBN as an Urothelial Carcinogen. C. VASCONCELOS-NÓBREGA, A. COLAÇO, C. LOPES, P. A. OLIVEIRA (Vise; Vila Real; Oporto, Portugal). In Vivo 26: 727-739, 2012.
In Vivo Models for Measuring Placental Glutatione-S-transferase (GST-P 7-7) Levels: A Suitable Biomarker for Understanding Cancer Pathogenesis. J. NOGUTI, L.F. BARBISAN, A. CESAR, C.D. SEABRA, R.B. CHOUERI, D.A. RIBEIRO (Sao Paulo, Brazil). In Vivo 26: 647-650, 2012.
Mouse Models of Inflammatory Bowel Disease - Insights into the Mechanisms of Inflammation-associated Colorectal Cancer. D. MLADENOVA, M.R.J. KOHONEN-CORISH (Sydney, NSW, Australia). In Vivo 26:  627-646, 2012.
Fluorescent Protein-based Tumor Models. V. YAGUBLU, Z. AHMADOVA, M. HAFNER, M. KEESE (Mannheim; Heidelberg; Frankfurt, Germany; Baku, Azerbaijan). In Vivo 26: 599-607, 2012.
Exploring Anticarcinogenic Agents in a Rat Hepatocarcinogenesis Model – Focus on Selenium and Statins. L. BJÖRKHEM-BERGMAN, L. EKSTRÖM, L.C. ERIKSSON (Stockholm, Sweden). In Vivo 26: 527-535, 2012.
The Effect of Insulin-like Growth Factor II in the Regulation of Tumour Cell Growth In Vitro and Tumourigenesis In Vivo. M. HALJE, M. NORDIN, D. BERGMAN, W, ENGSTRÖM (Uppsala, Sweden). In Vivo 26: 519-526, 2012.
In Vivo Models for Defining Molecular Subtypes of the Primitive Neuroectodermal Tumor Genome: Current Challenges and Solutions. J.D. LARSON, D.A. LARGAESPADA (Minneapolis, MN, USA). In Vivo 26: 487-500, 2012.
Oxidative Stress-mediated Biomolecular Damage and Inflammation in Tumorigenesis. F. SESTI, O.E. TSITSILONIS, A. KOTSINAS, I.P. TROUGAKOS (Athens, Greece). In Vivo 26: 395-402, 2012.
The Role of Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase-2 Inhibitors on Experimental Colitis. A.P. RIBEIRO PAIOTTI, P. MARCHI, S.J. MISZPUTEN, C.T. FUJIYAMA OSHIMA, M. FRANCO, D.A. RIBEIRO (São Paulo, SP, Brazil). In Vivo 26: 381-393, 2012.
Potential Therapy of Multidrug-resistant and Extremely Drug-resistant Tuberculosis with Thioridazine. L. AMARAL, J. MOLNAR (Lisbon, Portugal; Szeged, Hungary). In Vivo 26: 231-236, 2012.
Animal Models of N-Methyl-N-Nitrosourea-induced Mammary Cancer and Retinal Degeneration with Special Emphasis on Therapeutic Trials.
A. TSUBURA, Y.-C. LAI, H. MIKI, T. SASAKI, N. UEHARA, T. YURI, K. YOSHIZAWA (Moriguchi, Osaka, Japan). In Vivo 25: 11-22, 2011.
Diagnostics of Neuroendocrine Tumours.
M. HODOLI-, J. FETTICH, E. BANTI, S. CHONDROGIANNIS, A. AL-NAHHAS, D. RUBELLO (Ljubljana, Slovenia; Rovigo, Italy; London, UK). In Vivo 24: 771-774, 2010.
Comorbidity of Personality Disorders with Alcohol Abuse.
E. MELLOS, I. LIAPPAS, T. PAPARRIGOPOULOS (Athens, Greece). In Vivo 24: 761-770, 2010.
Colon Cancer Vaccines: An Update.
E. MERIKA, M.W. SAIF, A. KATZ, K. SYRIGOS, M. MORSE (London, UK; Haven, CT; Durham, NC, USA; Athens, Greece). In Vivo 24: 607-628, 2010.
In Vivo Research Using Early Life Stage Models.
R. SEABRA, N. BHOGAL (Nottingham, UK). In Vivo 24: 457-462, 2010.
Phenothiazines, Bacterial Efflux Pumps and Targeting the Macrophage for Enhanced Killing of Intracellular XDRTB.
L. AMARAL, A. MARTINS, J. MOLNAR, J.E. KRISTIANSEN, M. MARTINS, M. VIVEIROS, L. RODRIGUES, G. SPENGLER, I. COUTO, J. RAMOS, S. DASTIDAR, S. FANNING, M. MCCUSKER, J.-M. PAGES (Lisbon, Portugal; Szeged, Hungary; Kolkata, India; Dublin, Ireland; Marseille, France). In Vivo 24: 409-424, 2010.
Radioguided Surgery and Systemic Radionuclide Therapy of Neuroendocrine Tumours.
M. HODOLI-, J. FETTICH, M.C. MARZOLA, E. TONINI, A. AL-NAHHAS, D. RUBELLO (Ljubljana, Slovenia; Rovigo, Italy; London, UK). In Vivo 24: 97-100, 2010.
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors.
A. GLUBA, M. BANACH, D.P. MIKHAILIDIS, J. RYSZ (Lodz, Poland; London, UK). In Vivo 23: 797-812, 2009.
Muscle Regeneration: Cellular and Molecular Events.
M. KARALAKI, S. FILI, A. PHILIPPOU, M. KOUTSILIERIS (Athens, Greece). In Vivo 23: 779-796, 2009.
Vitamin Free Radicals and their Anticancer Action.
N. GETOFF (Vienna, Austria). In Vivo 23: 599-612, 2009.
Hippocrates of Kos, the Father of Clinical Medicine, and Asclepiades of Bithynia, the Father of Molecular Medicine.
C. YAPIJAKIS (Athens, Greece). In Vivo 23: 507-514, 2009.
Auricular Chondrocytes Π From Benchwork to Clinical Applications.
C. NABZDYK, L. PRADHAN, J. MOLINA, E. PERIN, D. PANIAGUA, D. ROSENSTRAUCH (Berlin, Germany; Houston, TX; Boston, MA, USA). In Vivo 23: 369-380, 2009.
The Autoimmune Disease Complex Interstitial Pneumonia / Dermatomyositis in the Light of Endocrinology and Cancer Epidemiology.
M. KODAMA, M. KODAMA (Nagoya; Kushiro, Japan). In Vivo 23: 353-356, 2009.
J.S. GREENBERGER (Pittsburgh, PA, USA). In Vivo 23: 323-336, 2009.
Advanced Cancer of the Ovary: Intraperitoneal Chemotherapy as a New Therapeutical Option.
The Use of Animal Models in the Study of Diabetes Mellitus.
A. CHATZIGEORGIOU, A. HALAPAS, K. KALAFATAKIS, E. KAMPER (Athens, Greece). In Vivo 23: 245-258, 2009.
Current Role and Future Perspectives of Hyperthermia for Prostate Cancer Treatment.
G. BARONZIO, A. GRAMAGLIA, G. FIORENTINI (Monza; Empoli, Italy). In Vivo 23: 143-146, 2009.
Fertility Preservation for Young Female Cancer Patients.
T. MALTARIS, M.W. BECKMANN, R. DITTRICH (Erlangen, Germany). In Vivo 23: 123-130, 2009.
Drug Resistance of Human Immunodeficiency Virus and Overcoming it by Natural Products.
J. HUPFELD, T. EFFERTH (Heidelberg, Germany). In Vivo 23: 1-6, 2009.
18F-FDG PET in the Diagnosis and Follow-up of Thyroid Malignancy.
A. AL-NAHHAS, S. KHAN, A. GOGBASHIAN, E. BANTI, L. RAMPIN, D. RUBELLO (London, UK; Rovigo, Italy). In Vivo 22: 109-114, 2008.
Estrogen and Progesterone Treatment Mimicking Pregnancy for Protection from Breast Cancer.
A. TSUBURA, N. UEHARA, Y. MATSUOKA, K. YOSHIZAWA, T. YURI (Osaka, Japan). In Vivo 22: 191-202, 2008.
Control of Interstitial Pneumonia by Drip Infusion of Megadose Vitamin C, Dehydroepiandrosterone and Cortisol. A Short Review of our Experience.
M. KODAMA, A. OYAMA, H. TAKAGI (Nagoya, Japan). In Vivo 22: 263-268, 2008.
The Role of the Insulin-like Growth Factor 1 (IGF-1) in Skeletal Muscle Physiology.
A. PHILIPPOU, M. MARIDAKI, A. HALAPAS, M. KOUTSILIERIS (Athens, Greece). In Vivo 21: 45-55, 2007.
Antioxidant Gene Therapeutic Approaches to Normal Tissue Radioprotection and Tumor Radiosensitization.
J.S. GREENBERGER, M.W. EPPERLY (Pittsburgh, PA, USA). In Vivo 21: 141-146, 2007.
TNF/VEGF Cross-talk in Chronic Inflammation-related Cancer Initiation and Progression: An Early Target in Anticancer Therapeutic Strategy.
F. GUADAGNI, P. FERRONI, R. PALMIROTTA, I. PORTARENA, V. FORMICA, M. ROSELLI (Rome, Italy). In Vivo 21: 147-162, 2007.
Photooxygenation, Photodegradation and Antioxidative Activity of Platonin, a Cyanine Photosensitizing Dye.
M. ISHIHARA, S. FUJISAWA (Saitama, Japan). In Vivo 21: 163-174, 2007.
Facts and Fiction of Phytotherapy for Prostate Cancer: A Critical Assessment of Preclinical and Clinical Data.
E.C. VON L…W, F.G.E. PERABO, R. SIENER, S.C. M†LLER (Bonn, Germany). In Vivo 21: 189-204, 2007.
Acridine Orange Could be an Innovative Anticancer Agent under Photon Energy.
K. KUSUZAKI, H. MURATA, T. MATSUBARA, H. SATONAKA, T. WAKABAYASHI, A. MATSUMINE, A. UCHIDA (Tsu; Kyoto, Japan). In Vivo 21: 205-214, 2007.
The Endoplasmic Reticulum: A Target for New Anticancer Drugs.
J. BOELENS, S. LUST, F. OFFNER, M.E. BRACKE, B.W. VANHOECKE (Ghent, Belgium). In Vivo 21: 215-226, 2007.
Comparison of Multidrug Resistant Efflux Pumps of Cancer and Bacterial Cells with Respect to the Same Inhibitory Agents.
L. AMARAL, H. ENGI, M. VIVEIROS, J. MOLN-R (Lisboa, Portugal; Szeged, Hungary). In Vivo 21: 237-244, 2007.
Clinical Pharmacokinetics of Bortezomib.
D. LEV-QUE, M. CHRISTINE M. CARVALHO, F. MALOISEL (Strasbourg, France). In Vivo 21: 273-278, 2007.
Selective Toxicity and Type of Cell Death Induced by Various Natural and Synthetic Compounds in Oral Squamous Cell Carcinoma.
H. SAKAGAMI, M. KOBAYASHI, C.-H. CHIEN, H. KANEGAE, M. KAWASE (Saitama; Ehime, Japan). In Vivo 21: 311-320, 2007.
Molecular Background of Chemoresistance in Pancreatic Cancer.
A. ZALATNAI, J. MOLN-R (Budapest; Szeged, Hungary). In Vivo 21: 339-348, 2007.
Pro-and Anti-angiogenesis Effects of Resveratrol.
Y. CHEN, S.-H. TSENG (Taipei; Taoyuan, Taiwan, ROC). In Vivo 21:365-370, 2007.
Evidence-based Complementary Oncology. Innovative Approaches to Optimize Standard Therapy Strategies.
J. BEUTH, J.M. SCHIERHOLZ (Cologne; Rosenfeld, Germany). In Vivo 21: 423-428, 2007.
Advances in Skeletal Muscle Tissue Engineering.
J. STERN-STRAETER, F. RIEDEL, G. BRAN, K. H…RMANN, U.R. GOESSLER (Mannheim, Germany). In Vivo 21: 435-444, 2007.
Leukocyte and Endothelial Cell Adhesion Molecules in Inflammation Focusing on Inflammatory Heart Disease.
C. GOLIAS, E. TSOUTSI, A. MATZIRIDIS, P. MAKRIDIS, A. BATISTATOU, K. CHARALABOPOULOS (Ioannina; Edessa, Greece). In Vivo 21: 757-770, 2007.
Animal Models of Carcinogenesis in the Digestive System.
C. TSIGRIS, M. KONSTANTAKAKI, C. XIROMERITIS, N. NIKITEAS, A. YANNOPOULOS (Athens, Greece). In Vivo 21: 803-812, 2007.
HuR, an RNA-binding Protein, Involved in the Control of Cellular Differentiation.
J. CHERRY, V. KARSCHNER, H. JONES, P.H. PEKALA (Greenville, NC, USA). In Vivo 20: 17-24, 2006.
The Natural Chemopreventive Compound Indole-3-carbinol: State of the Science.
E.G. ROGAN (Omaha, NE, USA). In Vivo 20: 221-228, 2006.
Critical Roles of Glutamine as Nitrogen Donors in Purine and Pyrimidine Nucleotide Synthesis: Asparaginase Treatment in Childhood Acute Lymphoblastic Leukemia.
J.G. CORY, A.H. CORY (Greenville, NC, USA). In Vivo 20: 587-590, 2006.
Hyperthermia and Immunity. A Brief Overview.
G. BARONZIO, A. GRAMAGLIA, G. FIORENTINI (Monza; Empoli, Italy). In Vivo 20: 689-696, 2006.
Anticancer Drug Delivery with Nanoparticles.
M. CONTI, V. TAZZARI, C. BACCINI, G. PERTICI, L.P. SERINO, U. DE GIORGI (Forl-; Pisa; Empoli, Italy). In Vivo 20: 697-702, 2006.
The PTHrP/PTH.1-R Bioregulation System in Cardiac Hypertrophy: Possible Therapeutic Implications.
A. HALAPAS, E. DIAMANTI-KANDARAKIS, D. KREMASTINOS, M. KOUTSILIERIS (Athens, Greece). In Vivo 20: 837-844, 2006.
New Anticancer Agents: In Vitro and In Vivo Evaluation.
D. ZIPS, H.D. THAMES, M. BAUMANN (Dresden, Germany; Houston, TX, USA). In Vivo 19: 1-8, 2005.
Radiometallation of Receptor-specific Peptides for Diagnosis and Treatment of Human Cancer.
M.F. GIBLIN, B. VEERENDRA, C.J. SMITH (Columbia, MO, USA). In Vivo 19: 9-30, 2005.
New Anticancer Agents: In Vitro and In Vivo Evaluation of the Antitumor and Antimetastatic Actions of Various Compounds Isolated from Medicinal Plants.
Y. KIMURA (Ehime, Japan). In Vivo 19: 37-60, 2005.
On the Potential Use of Flavonoids in the Treatment and Prevention of Pancreatic Cancer.
A.B. ROGINSKY, M.B. UJIKI, X.-Z. DING, T.E. ADRIAN (Chicago, IL, USA). In Vivo 19: 61-68, 2005.
Clinical Pharmacokinetics of Imatinib Mesylate.
D. LEVƒQUE, F. MALOISEL (Strasbourg, France). In Vivo 19: 77-84, 2005.
Potential Role of Cell Cycle Synchronizing Agents in Combination Treatment Modalities of Malignant Tumors.
A. ZALATNAI (Budapest, Hungary). In Vivo 19: 85-92, 2005.
Novel Camptothecin Derivatives.
K. LEGARZA, L.-X. YANG (San Francisco, CA, USA). In Vivo 19: 283-292, 2005.
Anticancer Compounds and Sphingolipid Metabolism in the Colon.
R.-D. DUAN (Lund, Sweden). In Vivo 19: 293-300, 2005.
Contribution of Chitosan and its Derivatives to Cancer Chemotherapy.
Y. KATO, H. ONISHI, Y. MACHIDA (Baltimore, MD, USA; Tokyo, Japan). In Vivo 19: 301-310, 2005.
In Vitro and In Vivo Antiresorptive Effects of Bisphosphonates in Metastatic Bone Disease.
I. KANAKIS, O.CH. KOUSIDOU, N.K. KARAMANOS (Patras, Greece). In Vivo 19: 311-318, 2005.
Cell Cycle and Apoptosis Deregulation in Classical Hodgkin Lymphomas.
M. BAI, A. PAPOUDOU-BAI, P. KITSOULIS, N. HORIANOPOULOS, S. KAMINA, N.J. AGNANTIS, P. KANAVAROS (Ioannina, Greece). In Vivo 19: 439-454, 2005.
Novel Agents in the Treatment of Non-small Cell Lung Cancer: Implications for Neoadjuvant Chemotherapy?
M. BERGQVIST, R. HENRIKSSON, D. BRATTSTR…M (Uppsala; UmeŒ, Sweden). In Vivo 19: 523-534, 2005.
The Soluble p51 Protein in Cancer Diagnosis, Prevention and Therapy.
I. ZUSMAN (Rehovot, Israel). In Vivo 19: 591-598, 2005.
Novel Insights into the Mechanism of Action of Intravesical Immunomodulators.
D.N. MITROPOULOS (Athens, Greece). In Vivo 19: 611-622, 2005.
In Vivo and In Vitro Decondensation of Human Sperm and Assisted Reproduction Technologies.
G.S. CAGLAR, M. HAMMADEH, B. ASIMAKOPOULOS, N. NIKOLETTOS, K. DIEDRICH, S. AL-HASSANI (L-beck; Homburg/Saar, Germany; Alexandroupolis, Greece). In Vivo 19: 623-630, 2005.
Skin Cancer in the Elderly.
K.N. SYRIGOS, I. TZANNOU, N. KATIRTZOGLOU, E. GEORGIOU (Athens, Greece). In Vivo 19: 643-652, 2005.
The Antitumor Activities of Flavonoids.
C. KANADASWAMI, L.-T. LEE, P.-P. H LEE, J.-J. HWANG, F.-C. KE, Y.-T. HUANG, M.-T. LEE (Buffalo, NY; Carrollton, TX, USA; Chia-Yi; Taipei; Kaohsiung, Taiwan, ROC). In Vivo 19: 895-910, 2005.
Impairments of the 2-5A Synthetase/RNase L Pathway in Chronic Fatigue Syndrome.
J. NIJS, K. DE MEIRLEIR (Brussels; Antwerp, Belgium). In Vivo 19: 1013-1022, 2005.
The Antitumor Activities of Flavonoids.
C. KANADASWAMI, L.-T. LEE, P.-P. H LEE, J.-J. HWANG, F.-C. KE, Y.-T. HUANG, M.-T. LEE (Buffalo, NY; Carrollton, TX, USA; Chia-Yi; Taipei; Kaohsiung, Taiwan, ROC). In Vivo 19: 895-910, 2005.
Impairments of the 2-5A Synthetase/RNase L Pathway in Chronic Fatigue Syndrome.
J. NIJS, K. DE MEIRLEIR (Brussels; Antwerp, Belgium). In Vivo 19: 1013-1022, 2005.

IMPORTANT NOTE: You may submit your article only through our online submission system